← Eichor
Condition: Healthy Adult Subjects Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Healthy Adult Subjects

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults
NA · 1 location(s) · Scott Silveira · NCT07144527Acute Effects of Aerobic Exercise and High-intensity Interval Exercise With Immersive Virtual Reality
NA · 1 location(s) · University of Valencia · NCT07101341A Study of HDM1002 Tablets on Cardiac Repolarization in Healthy Subjects
Phase 1 · 1 location(s) · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · NCT07594847Phase I Study of CPD704 Inhalation Suspension in Healthy Subjects
Phase 1 · 1 location(s) · Beijing Tide Pharmaceutical Co., Ltd · NCT07301203A Study to Evaluate How Multiple Doses of Itraconazole Interacts With Nacresertib in Healthy Adult Participants
Phase 1 · 1 location(s) · AbbVie · NCT07649954Assessing and Improving Quantitative Magnetic Resonance Imaging Metrics in Human Subjects
Phase N/A · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT05604534Safety, Tolerability and Pharmacokinetic Studies of HRS-2183 for Injection in Healthy Chinese Subjects After Single and
Phase 1 · 1 location(s) · Jiangsu HengRui Medicine Co., Ltd. · NCT07232758The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under
Phase 1 · 1 location(s) · Aspargo Labs, Inc · NCT06872866Effects of Hip Bump Manipulation Versus Sham Treatment in Healthy Adults
NA · 1 location(s) · Dominican University New York · NCT07025434A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020
Phase 1 · 1 location(s) · Luye Pharma Group Ltd. · NCT07230652A Study of SN2001 Dose, Safety & Immunogenicity in Healthy Adults
Phase 1 · 1 location(s) · Chimivac INC · NCT07059403A Phase 1 Study to Assess the Effect of Itraconazole on ABBV-722 in Healthy Adult Participants
Phase 1 · 1 location(s) · AbbVie · NCT07599761A Phase 1, Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISM8969
Phase 1 · 1 location(s) · InSilico Medicine Hong Kong Limited · NCT07581431Dynamic Cardio-vascular, Cerebro-vascular and Cortical Interaction in Healthy Adult Subjects
NA · 1 location(s) · IRCCS Policlinico S. Donato · NCT06785181A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis
Phase 1 · 1 location(s) · Usynova Pharmaceuticals Ltd. · NCT07038720Food Effect on PK of DW-1021 (Pelubiprofen 45 mg / Tramadol 45.9 mg) in Healthy Adults
Phase 1 · 2 location(s) · Haiphong University of Medicine and Pharmacy · NCT07060209Phase I Study of XTL6001 Injection in Healthy and Obese Subjects
Phase 1 · 1 location(s) · Shanghai Xitaili Biomedicine Technology co., Ltd. · NCT07205432Comparison of DW-1021 and Separate Doses of Pelubi CR and Zytram CR Under Fasting Conditions
Phase 1 · 2 location(s) · Haiphong University of Medicine and Pharmacy · NCT07032558A Study to Evaluate Single-dose of HB0056 in Healthy Adult Participants
Phase 1 · 1 location(s) · Shanghai Huaota Biopharmaceutical Co., Ltd. · NCT06612970Bioequivalence Study of GZR18 Injection Before and After CMC Change
Phase 1 · 1 location(s) · Gan & Lee Pharmaceuticals. · NCT07355738Effects of Combined Heat Application and Acupressure to the Carotid Artery Region on Cerebral Blood Flow in Healthy Adul
NA · 1 location(s) · Pusan National University Yangsan Hospital · NCT07324226A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects
Phase 1 · 1 location(s) · TIXiMED, Inc. · NCT07675590PK, PD, Safety and Immunogenicity Study of Erythropoietin of Incepta Pharmaceuticals Ltd With Eprex (Janssen-Cilag).
Phase 3 · 1 location(s) · Incepta Pharmaceuticals Ltd · NCT07025681A Study To Characterize Mass Balance Of [14C] HDM1002 in Chinese Healthy Subjects
Phase 1 · 1 location(s) · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · NCT06576401A Study to Assess How Intravenous and Subcutaneous Administrations of Risankizumab Moves Through the Body of Healthy Adu
Phase 1 · 2 location(s) · AbbVie · NCT07466550A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALE1 in Healthy Adults and Adults With
Phase 1/Phase 2 · 2 location(s) · Alesta Therapeutics · NCT07179640A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BAL2420 in Healthy Adult Subjects
Phase 1 · 1 location(s) · Basilea Pharmaceutica · NCT07500181A Clinical Trial Evaluating TQF3250 Capsules in Healthy Adult Subjects
Phase 1 · 1 location(s) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT07327281A Study of JPH034 in Healthy Adult Participants
Phase 1 · 1 location(s) · J-Pharma Co., Ltd. · NCT07534657Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepati
Phase 1 · 2 location(s) · Atea Pharmaceuticals, Inc. · NCT06911320
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.